The Product. The Chemicals. The Diagnosis.

Starting around 1995, Kiara Burroughs bought and applied chemical hair relaxer products on a cycle of every six to eight weeks. She used a Strength of Nature product from 1995 through 2007, switching between two specific formulations. She then purchased two different L’Oréal hair relaxer products from 2003 through 2014. That is roughly nineteen years of repeated chemical exposure applied directly to her scalp.

In March 2018, Burroughs received a diagnosis of uterine fibroids. Her mother had a documented history of fibroids and had also used hair relaxers. In October 2022, a scientific study was released and publicized linking the use of chemical hair straighteners and relaxers to uterine cancer. Burroughs filed her lawsuit on October 27, 2022, within weeks of learning about that research.

The lawsuit alleges the hair relaxers Burroughs used contained phthalates and other endocrine-disrupting chemicals that elevated her risk of developing uterine fibroids, cancer, and endometriosis. The legal claim is strict products liability: the products were defective in their condition when sold, and that defective condition caused her injury.

They Knew The Clock. They Counted On It.

L’Oréal and Strength of Nature did not respond to the lawsuit by disputing the science. Their opening move was procedural. They filed motions to dismiss, arguing that Georgia law bars any strict products liability claim filed more than ten years after the first sale of the product in question. Since Burroughs first bought a Strength of Nature product in 1995 and first bought an L’Oréal product in 2003, they argued the ten-year clock had run out 27 years and 19 years ago, respectively, before she even filed her lawsuit.

The strategy was elegant in its cynicism: frame the entire chain of products Burroughs used over her lifetime as a single legal event anchored to the earliest bottle she ever bought. If the clock started ticking in 1995, it expired in 2005. Everything she bought after 2005 would become legally invisible, shielded from liability by the passage of time regardless of what was in those bottles and what those chemicals did to her body.

A lower appeals court initially agreed with L’Oréal and Strength of Nature and reversed the trial court’s denial of the dismissal motions. The Georgia Supreme Court granted review to settle the question once and for all. On October 15, 2025, the state’s highest court unanimously ruled against the corporations.

The Non-Financial Ledger: What No Settlement Can Repay

Kiara Burroughs did not make a reckless choice. She made the same choice that millions of Black women in America have made for decades: she bought a product marketed to her community, applied it to her own body on a doctor-regular schedule, and trusted that the corporations selling it had done their homework. She used these products every six to eight weeks for approximately nineteen years. That is not casual exposure. That is a lifestyle built around a product that the lawsuit alleges was chemically compromised from the moment it left the factory floor.

Uterine fibroids are a condition that profoundly disrupts a person’s life. They cause chronic pelvic pain, heavy menstrual bleeding, pressure on the bladder and bowel, and in many cases, complications with fertility and pregnancy. They are one of the leading reasons women undergo hysterectomy in the United States. To live with fibroids is to negotiate with your own body constantly, to plan your life around a diagnosis that the medical establishment has historically under-researched, undertreated, and dismissed, particularly in Black women, who develop fibroids at higher rates and more severely than other groups.

The fact that Burroughs’s mother also had a history of fibroids and also used hair relaxers sits in the complaint like a quiet devastation. That detail raises a question no court ruling can answer: was this a generational harm? Did a product line marketed specifically to Black women travel from mother to daughter not just as a beauty routine, but as a vector of disease? We do not know. But Burroughs knew enough to sue, and that act of courage is what put this question before the highest court in Georgia.

What compounds the betrayal is the timeline of knowledge. The scientific study linking chemical hair straighteners and relaxers to uterine cancer was released and publicized in October 2022, and Burroughs filed her lawsuit within weeks. She did not sit on this information. She acted. The corporations’ response was to say that she had waited too long, that the legal clock had already run out, that her window to seek accountability closed years before she even knew she had a reason to open it. That is the system working exactly as corporations designed it to work.

Legal Receipts: The Court’s Most Damning Passages

The Georgia Supreme Court’s opinion is a methodical takedown of the corporations’ legal strategy. These are the passages that matter most.

“She bought and used one such product, manufactured by Strength of Nature, from 1995 until 2002; a different Strength of Nature product from 2003 until 2007; and a third such product from 2007 until 2014. She also bought and used two different L’Oreal hair-relaxer products from 2003 until 2014. All told, she applied these hair-relaxer products every six to eight weeks from 1995 to 2001 and then from 2002 to 2014.” Supreme Court of Georgia, Burroughs v. Strength of Nature Global, LLC / L’Oréal USA, Inc., October 15, 2025. Background section, describing Burroughs’s use pattern as alleged in her complaint.

“Burroughs alleged that the hair-relaxer products she used that were manufactured by L’Oreal and Strength of Nature contained phthalates and other endocrine-disruptive chemicals that increased the risk of developing diseases including uterine fibroids, cancer, and endometriosis.” Supreme Court of Georgia, Burroughs v. L’Oréal USA, Inc., October 15, 2025. Background section, summarizing the core factual allegations of the complaint.

“Whatever its surface appeal, this theory of construction falls apart on closer inspection… that word cannot simultaneously carry a second, entirely different meaning and purpose, like a linguistic chameleon that changes its meaning and purpose on the fly depending on the facts of the case. Simply put, this is not how language works.” Supreme Court of Georgia, October 15, 2025. Analysis section, rejecting the manufacturers’ statutory interpretation argument that would have shielded all products behind the earliest sale date.

“The statute of repose is applied on a per-unit basis. In other words, OCGA § 51-1-11(b)(2) creates a ten-year statute of repose that begins to run on each sale of a unit as new to an intended end user.” Supreme Court of Georgia, October 15, 2025. Analysis section, setting the binding legal rule that reverses the Court of Appeals and allows Burroughs’s claims to proceed.

“The statutory language setting out the statute of repose here does not seem to contemplate or account for theories of liability based on a plaintiff’s exposure to a combination of many units of a product over a long period of time. A legislative solution may well be better than any answer a court could come up with given the current statute.” Supreme Court of Georgia, October 15, 2025. Footnote 6, noting that the law itself may be inadequate to handle cumulative-exposure cases and suggesting the legislature may need to act.

Societal Impact Mapping

Public Health: An Industry-Wide Reckoning on Endocrine Disruption

The chemicals at the center of this lawsuit, phthalates and other endocrine-disrupting compounds, do not work like a poison you ingest once and feel immediately. They interfere with the body’s hormonal signaling system over time, accumulating through repeated exposure and potentially disrupting the processes that regulate reproductive health. Burroughs applied these products to her scalp, the body’s largest and most permeable organ, every six to eight weeks for roughly nineteen years. The complaint directly links this repeated exposure to her uterine fibroid diagnosis.

The court itself referenced cases involving talc-based baby powder linked to ovarian cancer after more than four decades of daily use, and a case involving microwave popcorn butter flavoring consumed daily for twenty-five years. These cases exist in the opinion not as decoration but as legal precedent: cumulative exposure injury from consumer products is a recognized category of harm, and the courts are grappling with how to handle it under liability frameworks written for single-product, single-exposure injuries.

This case also makes visible a public health reality that hits Black women hardest. Chemical hair relaxers have been marketed almost exclusively to Black women and girls for generations. Research consistently shows that Black women develop uterine fibroids at two to three times the rate of white women, experience symptoms earlier, and have more severe outcomes. If phthalates and endocrine-disrupting chemicals in relaxers contribute to that disparity, the health impact extends far beyond one plaintiff in one courtroom. This is a potential mass public health failure, and the Georgia Supreme Court just ensured the evidence cannot be buried under a procedural technicality.

Economic Inequality: Who Gets Hurt When The Clock Runs Out

The statute of repose that L’Oréal and Strength of Nature tried to weaponize is, at its core, a corporate protection mechanism. It exists to give manufacturers certainty: after ten years, they cannot be sued for a product regardless of what it does to someone’s body. The economic logic is that businesses need to be able to close their books on liability exposure. The human logic is that the people most likely to be harmed by slow-acting chemical exposure, people who cannot afford frequent medical check-ups, people whose doctors may dismiss their symptoms, people who did not read a scientific journal in October 2022, are the people most likely to miss the legal window entirely.

Burroughs’s mother also used hair relaxers and also had fibroids. The products were affordable, widely available, and culturally normalized. A household that cannot afford premium alternatives to these products is also a household that is more likely to keep using the same product for decades, precisely the usage pattern that the corporations argued should legally immunize them from any accountability. The economic structure of who uses chemical relaxers and why is inseparable from the legal structure that tried to protect the companies that make them.

The Georgia Supreme Court’s ruling that the clock resets with each bottle sold levels this dynamic, at least slightly. A woman who bought L’Oréal hair relaxer in 2015, 2016, 2017, and beyond now has a viable legal basis to pursue claims for those specific purchases, even if earlier bottles are time-barred. That is not a complete solution. The burden of proving that those specific bottles caused her specific injury remains on her, and the court acknowledged that proving such causation is a “tricky undertaking.” But the corporations no longer get to point to 1995 and say: case closed.

The “Cost of a Life” Metric

What Now: Where To Put Your Energy

The Corporate Defendants Still In This Fight

• L’Oréal USA, Inc. — named defendant, hair relaxer product line under legal scrutiny
• Strength of Nature Global, LLC — named defendant, three distinct hair relaxer products at issue
• Namaste Laboratories, LLC — named in the original complaint as an additional manufacturer; not a party to this specific appeal

The Watchlist: Who Should Be Paying Attention

• FDA: Chemical hair relaxers are regulated as cosmetics; the FDA’s authority to require safety testing of cosmetic ingredients is limited and routinely exploited
• FTC: Marketing of chemical hair relaxers to Black women communities warrants scrutiny for deceptive trade practices if health risks were known and not disclosed
• CPSC: Consumer Product Safety Commission has authority over products that cause injury; phthalate levels in cosmetic products warrant formal review
• Georgia Legislature: The court itself identified that the current statute may be inadequate for cumulative-exposure injury cases and suggested a legislative solution
• NIH/NIEHS: The National Institute of Environmental Health Sciences funded research connecting chemical hair products to uterine disease; continued and expanded funding matters

What You Can Actually Do Right Now

If you or someone you know has used chemical hair relaxers and received a uterine fibroid, cancer, or endometriosis diagnosis, document your product use history now. Names, dates, approximate frequency. This information is legally relevant and time-sensitive. Connect with reproductive justice organizations in your area, particularly those with experience in environmental health and Black women’s health advocacy. Organizations like the Black Women’s Health Imperative work specifically on closing the research and policy gaps that allowed this harm to continue unaddressed for decades. Mutual aid networks in your community can help cover costs for medical second opinions if your current provider has dismissed your concerns. The court has kept the door open. The corporations will spend significant resources trying to close it before trial. Your story, documented and shared with the right organizations, is part of what keeps that door open.